Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score‐matched analysis

BACKGROUND: To investigate the survival benefit of concurrent chemoradiotherapy (CCRT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC) during the years of intensity‐modulated radiotherapy (IMRT). METHODS: Medical records of 1089 patients with ESCC who received IMRT from...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chen, Tan, Lijun, Liu, Xiao, Wang, Xin, Zhou, Zongmei, Chen, Dongfu, Feng, Qinfu, Liang, Jun, Lv, Jima, Wang, Xiaozhen, Bi, Nan, Deng, Lei, Wang, Wenqing, Zhang, Tao, Ni, Wenjie, Chang, Xiao, Han, Weiming, Gao, Linrui, Wang, Shijia, Xiao, Zefen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201542/
https://www.ncbi.nlm.nih.gov/pubmed/33949784
http://dx.doi.org/10.1111/1759-7714.13971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201542/
https://www.ncbi.nlm.nih.gov/pubmed/33949784
http://dx.doi.org/10.1111/1759-7714.13971

Ejemplares similares